SIC 2834 – Pharmaceutical Preparations
Valuation | |
---|---|
Market Cap ($M) | 8.46 |
Enterprise Value ($M) | 4.67 |
Book Value ($M) | 25.76 |
Book Value / Share | 8.58 |
Price / Book | 0.33 |
NCAV ($M) | 18.98 |
NCAV / Share | 6.33 |
Price / NCAV | 0.45 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | 0.14 |
Return on Assets (ROA) | 0.08 |
Return on Equity (ROE) | 0.10 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 4.94 |
Current Ratio | 4.94 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 29.71 |
Assets | 36.48 |
Liabilities | 10.72 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 16.02 |
Operating Income | 5.58 |
Net Income | 3.59 |
Earnings Per Share Basic And Diluted | n/a |
Earnings Per Share Diluted | n/a |
Earnings Per Share Basic | n/a |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | 8.56 |
Cash from Investing | -22.66 |
Cash from Financing | 15.50 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13G/A | Alyeska Investment Group, L.P. | 2.50 | -70.50 | |
13G/A | Goldman Sachs Group Inc | 0.00 | -99.93 | |
13G/A | Hirschman Orin | 8.50 | -88.89 | |
13G | Nantahala Capital Management, LLC | 9.99 | ||
13G/A | Lind Global Fund II LP | 3.50 | -87.08 | |
13G | ADAR1 Capital Management, LLC | 9.99 | ||
13G/A | Stonepine Capital Management, LLC | 9.99 | -87.25 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
File Date | Form | SEC Filings |
---|---|---|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
651 | 4,012 | 16.23 | |
2,569 | 12,309 | 20.87 | |
130 | 3,356 | 3.87 | |
56 | 1,099 | 5.10 | |
(click for more detail) |
Similar Companies | |
---|---|
JAGX – Jaguar Health, Inc. | JSPR – Jasper Therapeutics, Inc. |
KALA – KALA BIO, Inc. | KRRO – Korro Bio, Inc. |
KTTA – Pasithea Therapeutics Corp. |
Financial data and stock pages provided by
Fintel.io